Cellular dichotomy between anchorage-independent growth responses to bFGF and TPA reflects molecular switch in commitment to carcinogenesis

Molecular Carcinogenesis

Volumn 48, Issue 11, 2009, Pages 1059-1069

  Waters, Katrina M ^a   Ruimin, Tan ^a   Opresko, Lee K ^a   Quesenberry, Ryan D ^a   Bandyopadhyay, Somnath ^a   Chrisler, William B ^a   Weber, Thomas J ^a  

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Anchorage independent growth; Hepatic leukemia factor; Reversible

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BINDING PROTEIN; D SITE ALBUMIN PROMOTER BINDING PROTEIN; HEPATIC LEUKEMIA FACTOR; HEPATOCYTE NUCLEAR FACTOR 4; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSCRIPTION FACTOR SP1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; GAMMA RADIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IONIZING RADIATION; MALIGNANT TRANSFORMATION; MELANOMA; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION CARCINOGENESIS;

ANIMALS; BASE SEQUENCE; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL ADHESION; CELL DIVISION; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DNA PRIMERS; DNA-BINDING PROTEINS; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 70350441659     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20558     Document Type: Article

References (42)

1. Hall EJ, Henry S. Kaplan Distinguished Scientist Award 2003. The crooked shall be made straight; dose-response relationships for carcinogenesis. Int J Radiat Biol 2004;80:327-337.
2. Snyder AR. Review of radiation-induced bystander effects. Hum Exp Toxicol 2004;23:87-89.
3. Morgan WF, Day JP, Kaplan MI, McGhee EM, Limoli CL. Genomic instability induced by ionizing radiation. Radiat Res 1996;146:247-258. (Pubitemid 26320088)
4. Wolff S. The adaptive response in radiobiology: Evolving insights and implications. Environ Health Perspect 1998;106:277-283.
5. Calabrese EJ, Baldwin LA. The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci 2001;62:330-338. (Pubitemid 32707748)
6. Weber TJ, Siegel RW, Markillie LM, Chrisler WB, Lei XC, Colburn NH. A paracrine signal mediates the cell transformation response to low dosegammaradiation in JB6 cells. Mol Carcinog 2005;43:31-37.
7. Colburn NH, Former BF, Nelson KA, Yuspa SH. Tumour promoter induces anchorage independence irreversibly. Nature 1979;281:589-591.
8. Takahashi K, Heine UI, Junker JL, Colburn NH, Rice JM. Role of cytoskeleton changes and expression of the H-ras oncogene during promotion of neoplastic transformation in mouse epidermal JB6 cells. Cancer Res 1986;46:5923-5932. (Pubitemid 17178006)
9. Howson KM, Aplin AC, Gelati M, Alessandri G, Parati EA, Nicosia RF. The postnatal rat aorta contains pericyte progenitor cells that form spheroidal colonies in suspension culture. Am J Physiol Cell Physiol 2005;289:C1396-C1407. (Pubitemid 41636345)
10. Cavallaro U, Soria MR, Montesano R. Exogenous fibroblast growth factor-2 induces a transformed phenotype in vascular kaposi's sarcoma-like cells. Mol Cell Biol Res Commun 2000;4:203-205. (Pubitemid 32592186)
11. Berking C, Takemoto R, Satyamoorthy K, Elenitsas R, Herlyn M. Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin. Am J Pathol 2001;158:943-953. (Pubitemid 32221786)
12. Ropiquet F, Berthon P, Villette JM, et al. Constitutive expression of FGF2/bFGF in nontumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype. Int J Cancer 1997;72:543-547. (Pubitemid 27325886)
13. Dotto GP, Moellmann G, Ghosh S, Edwards M, Halaban R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J Cell Biol 1989;109:3115-3128. (Pubitemid 20011935)
14. Ramon y Cajal S, Suster S, Halaban R, Filvaroff E, Dotto GP. Induction of different morphologic features of malignant melanoma and pigmented lesions after transformation of murine melanocytes with bFGF-cDNA and H-ras, myc, neu, and E1a oncogenes. Am J Pathol 1991;138:349-358.
15. Tanaka H, Takesada Y, Shibata MA, et al. Lack of tumor promoting effects of KCB-1, a recombinant human basic fibroblast growth factor, on two-stage skin carcinogenesis in female CD-1 (ICR) mice. Cancer Lett 1996;105:195-202. (Pubitemid 26252593)
16. Vassar R, Hutton ME, Fuchs E. Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Mol Cell Biol 1992;12:4643-4653.
17. Ackermann J, Beermann F. The fibroblast growth factor-2 is not essential for melanoma formation in a transgenic mouse model. Pigment Cell Res 2005;18:315-319. (Pubitemid 41032891)
18. Foletti A, Ackermann J, Schmidt A, Hummler E, Beermann F. Absence of fibroblast growth factor 2 does not prevent tumor formation originating from the RPE. Oncogene 2002;21:1841-1847. (Pubitemid 34259186)
19. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci USA 1998;95:5672-5677. (Pubitemid 28224154)
20. Weber TJ, Markillie LM, Chrisler WB, Vielhauer GA, Regan JW. Modulation of JB6 mouse epidermal cell transformation response by the prostaglandin F2alpha receptor. Mol Carcinog 2002;35:163-172.
21. Minard KR, Guo X, Wind RA. Quantitative 1H MRI and MRS microscopy of individual V79 lung tumor spheroids. J Magn Reson 1998;133:368-373. (Pubitemid 128450654)
22. Gentleman RC, Carey VJ, Bates DM, et al. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
23. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-193. (Pubitemid 36181903)
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate - A practical and powerful approach to multiple testing. J Roy Stat Soc B Met 1995;57:289-300.
25. Shah AR, Singhal M, Klicker KR, Stephan EG, Steven Wiley H, Waters KM. Enabling high-throughput data management for systems biology: The bioinformatics resource manager. Bioinformatics 2007;23:906-909. (Pubitemid 47049929)
26. Dennis G, Jr., Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003;4:R60.
27. Colburn NH, Bruegge WF, Bates JR, et al. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells. Cancer Res 1978;38:624-634. (Pubitemid 8311406)
28. Suzukawa K, Weber TJ, Colburn NH. AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model. Environ Health Perspect 2002;110:865-870.
29. Green CB, Takahashi JS. Xenobiotic metabolism in the fourth dimension: PARtners in time. Cell Metab 2006;4:3-4.
30. Falvey E, Fleury-Olela F, Schibler U. The rat hepatic leukemia factor (HLF) gene encodes two transcriptional activators with distinct circadian rhythms, tissue distributions and target preferences. EMBO J 1995;14:4307-4317.
31. Huang C, Ma WY, Young MR, Colburn N, Dong Z. Shortage of mitogen-activated protein kinase is responsible for resistance to AP-1 transactivation and transformation in mouse JB6 cells. Proc Natl Acad Sci USA 1998;95:156-161. (Pubitemid 28103923)
32. Luo B, Cheung HW, Subramanian A, et al. Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci USA 2008;105:20380-20385.
33. Brambrink T, Foreman R, Welstead GG, et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008;2:151-159. (Pubitemid 351168714)
34. Gazel A, Nijhawan RI, Walsh R, Blumenberg M. Transcriptional profiling defines the roles of ERK and p38 kinases in epidermal keratinocytes. J Cell Physiol 2008;215:292-308.
35. Wei D, Williams D, Browder W. Activation of AP-1 and SP1 correlates with wound growth factor gene expression in glucan-treated human fibroblasts. Int Immunopharmacol 2002;2:1163-1172. (Pubitemid 34899399)
36. Zhang X, Leav I, Revelo MP, et al. Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon. PLoS Genet 2009;5:e1000334.
37. Taraviras S, Monaghan AP, Schutz G, Kelsey G. Characterization of the mouse HNF-4 gene and its expression during mouse embryogenesis. Mech Dev 1994;48:67-79. (Pubitemid 24330941)
38. Mizuno T, Tokuoka S, Kishikawa M, Nakashima E, Mabuchi K, Iwamoto KS. Molecular basis of basal cell carcinogenesis in the atomic-bomb survivor population: p53 and PTCH gene alterations. Carcinogenesis 2006;27:2286-2294. (Pubitemid 44644818)
39. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 1994;137:S17-S67.
40. Kishikawa M, Koyama K, Iseki M, et al. Histologic characteristics of skin cancer in Hiroshima and Nagasaki: Background incidence andradiation effects. Int JCancer 2005;117:363-369. (Pubitemid 41430499)
41. Palmqvist L, Pineault N, Wasslavik C, Humphries RK. Candidate genes for expansion and transformation of hematopoietic stem cells by NUP98-HOX fusion genes. PLoS ONE 2007;2:e768.
42. Benito A, Gutierrez O, Pipaon C, et al. A novel role for proline- and acid-rich basic region leucine zipper (PAR bZIP) proteins in the transcriptional regulation of a BH3-only proapoptotic gene. J Biol Chem 2006;281:38351-38357. (Pubitemid 46041958)